Life Science Company Supports Clinical Trials in More Than 40 Languages and 78 Countries
New York, NY, April 26, 2011 – TransPerfect, the world’s largest privately held provider of translation services, today announced that it is working with Cenduit, whose interactive response technology (IRT) services enable the enrollment, randomization and treatment of patients in more than 650 clinical studies worldwide. Cenduit relies exclusively on TransPerfect services, technology and in-house studios to translate complex scripts and record prompts in more than 40 languages, accommodating the 78 countries in which Cenduit facilitates trials.
“When professional healthcare people use Cenduit systems to help manage patient enrollment and treatment in clinical trials, it is critically important that the questions and phrases that they see are clearly understood, accurate and unambiguous,” said Tony Frankland, global head of Sales and Marketing for Cenduit. “TransPerfect's experience and expertise in this field means that we can rely on the right phrase being provided every time, on time.”
Cenduit’s pharmaceutical, biotechnology and clinical research customers use Cenduit to manage patient randomization and drug supply management for their clinical studies, which encompass more than 16,000 sites and 220,000 subjects. TransPerfect provides an interactive online portal that enables Cenduit to efficiently manage the translation and recording work for its projects. This means that the activities of translation and recording are off the critical path thus helping to minimize the overall lead time to study start.
“IRT is an essential part of drug development, with 95 percent of all pharmaceutical companies employing it to conduct trials,” said Liz Elting, co-CEO of TransPerfect. “For Cenduit to meet the needs of that market, it must provide excellence in translation services as part of its overall service to clinical trials. We’re delighted to work with Cenduit to deliver translation services and technology and help contribute to the drug development process.”
With revenue of more than $250 million, TransPerfect is the largest privately held language services provider in the world. From offices in 66 cities on five continents, TransPerfect offers a full range of services in more than 100 languages to multinationals worldwide. With a global network of over 4,000 linguists and subject-area specialists, TransPerfect is the largest translation company to be fully ISO 9001:2008 and EN 15038:2006 certified. TransPerfect is headquartered in New York and has regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.